154 related articles for article (PubMed ID: 994377)
21. Disseminated intravascular coagulation in prostatic disease.
Deutsch E
Prog Clin Biol Res; 1976; 6():313-27. PubMed ID: 66693
[TBL] [Abstract][Full Text] [Related]
22. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
Colick JA; Fisher LM
Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
[No Abstract] [Full Text] [Related]
23. Characterization of the fibrinolytic state by measuring stable cross-linked fibrin degradation products in disseminated intravascular coagulation associated with acute promyelocytic leukemia.
Okajima K; Koga S; Okabe H; Inoue M; Takatsuki K
Acta Haematol; 1989; 81(1):15-8. PubMed ID: 2494830
[TBL] [Abstract][Full Text] [Related]
24. Biological behavior of higher molecular weight products of fibrinolysis.
Chang ML; Bang NU
J Lab Clin Med; 1977 Jul; 90(1):216-26. PubMed ID: 874368
[TBL] [Abstract][Full Text] [Related]
25. [Fibrin (ogen) Split products of nephropathies].
Anger H
Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody-based plasma assays for fibrin(ogen) and derivatives, and their clinical relevance.
Kroneman H; Nieuwenhuizen W; Knot EA
Blood Coagul Fibrinolysis; 1990; 1(1):91-111. PubMed ID: 2102791
[TBL] [Abstract][Full Text] [Related]
28. Evidence that fibrin(ogen) degradation products (FDP) are adequately quantified in citrated plasma defibrinated at low pH.
Godal HC; Hamborg T
Scand J Haematol; 1984 Jan; 32(1):46-8. PubMed ID: 6695150
[TBL] [Abstract][Full Text] [Related]
29. Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.
Yoshioka K; Mizuno S; Miyata H; Maki S
Eur J Pediatr; 1982 Feb; 138(1):46-8. PubMed ID: 7075627
[No Abstract] [Full Text] [Related]
30. Significance of intravascular coagulation and fibrinolysis in acute hepatic failure.
Hillenbrand P; Parbhoo SP; Jedrychowski A; Sherlock S
Gut; 1974 Feb; 15(2):83-8. PubMed ID: 4820641
[TBL] [Abstract][Full Text] [Related]
31. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC.
Taylor FB; Wada H; Kinasewitz G
Crit Care Med; 2000 Sep; 28(9 Suppl):S12-9. PubMed ID: 11007191
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of blood platelet counts, coagulation factors and serum fibrin/fibrinogen degradation products (FDP) in acute infections.
Skånsberg P; Berg B
Scand J Infect Dis; 1978; 10(1):61-5. PubMed ID: 635477
[TBL] [Abstract][Full Text] [Related]
33. Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique.
Connaghan DG; Francis CW; Lane DA; Marder VJ
Blood; 1985 Mar; 65(3):589-97. PubMed ID: 3971042
[TBL] [Abstract][Full Text] [Related]
34. Blood fibrinolysis and the kidney.
Goldschmidt B; Marosvári I
Lancet; 1968 Jul; 2(7558):48. PubMed ID: 4172705
[No Abstract] [Full Text] [Related]
35. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
36. [Disseminated intravascular coagulation and hyperfibrinolysis in dogs with metastasizing mammary carcinoma].
Mischke R; Wohlsein P; Busse L; Pohlenz J
Schweiz Arch Tierheilkd; 1998; 140(12):497-505. PubMed ID: 9863356
[TBL] [Abstract][Full Text] [Related]
37. [Changes in blood coagulation in glomerulonephritis].
Robeva R; Belovezhdov N; Genova V
Vutr Boles; 1982; 21(6):1-7. PubMed ID: 6219496
[No Abstract] [Full Text] [Related]
38. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
39. Coagulation, fibrinolysis, and kinin generation in adult cats.
O'Rourke L; Feldman BF; Ito RK
Am J Vet Res; 1982 Aug; 43(8):1478-80. PubMed ID: 7103232
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of patients with increased fibrinolytic split products (FSP) in their serum.
Cooper HA; Bowie EJ; Owen CA
Mayo Clin Proc; 1974 Sep; 49(9):654-7. PubMed ID: 4413314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
